Last updated on November 2017

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris


Brief description of study

Clinical research study for the treatment of moderate to severe acne vulgaris.

Detailed Study Description

The main purpose of this study is to evaluate the safety, efficacy, and tolerability of a once-daily topical application of IDP-126 Gel in subjects with moderate to severe acne. Subjects must be at least 9 years of age or older and generally healthy. IDP-126 Gel is a fixed dose combination of clindamycin phosphate, benzoyl peroxide (BPO), and adapalene. This study will compare IDP-126 Gel to its active gel components (clindamycin phosphate, BPO, adapalene), as well as its Vehicle Gel. “Vehicle” is a term to describe a gel that looks like the IDP-126 Gel but does not contain any active drug (similar to a placebo). If you decide to be in this research study, you may receive either the IDP-126 Gel, a combination of the individual components of the IDP-126 Gel (clindamycin phosphate, BPO, and/or adapalene), or the IDP-126 Vehicle Gel.

Participation will be approximately 12 weeks (3 months), including 6 in office visits:

You may receive up to $300.00 if you complete the whole study, as a compensation for your time and travel.

Clinical Study Identifier: TX154547

Contact Investigators or Research Sites near you

Start Over

Valerija Misev

Juva Skin and Laser Center
New York, NY USA
  Connect »